CTIC - CTi Biopharma Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CTi Biopharma Corp's activity chart (see below) currently has 39 price targets and 38 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.93% with an average time for these price targets to be met of 475.76 days.

Most recent stock forecast was given by from JMP on 24-May-2023. First documented stock forecast 09-Sep-2014.

Best performing analysts who are covering CTIC - CTi Biopharma Corp:

Chad Messer Gil Blum Leah Rush Cann Reni Benjamin Thomas Flaten

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 24-May-2023

3 years 4 months 1 days ago
(24-May-2023)

4/4 (100%)

$4.25 (89.47%)

144

Buy Since 17-Oct-2022

$9.1

$0.01 (0.11%)

$13

3 years 4 months 9 days ago
(16-May-2023)

1/2 (50%)

$0.19 (2.13%)

36

Buy Since 06-May-2021

$9.1

$0.01 (0.11%)

$8.1

3 years 4 months 10 days ago
(15-May-2023)

5/5 (100%)

$0.17 (1.90%)

108

Buy Since 02-Dec-2021

$9

3 years 4 months 14 days ago
(11-May-2023)

7/7 (100%)

$3.88 (75.78%)

236

Buy Since 13-Oct-2020

$9.1

$0.01 (0.11%)

$8

3 years 4 months 15 days ago
(10-May-2023)

2/2 (100%)

$0.17 (1.90%)

491

Show more analysts

Please expand the browser size to see the chart

What is CTIC (CTi Biopharma Corp) average time for price targets to be met?

On average it took 476 days for the stock forecasts to be reached, with an average price target met ratio of 81.93%.

Which analyst most recently updated their price target on CTIC (CTi Biopharma Corp)?

Which analyst has the most public recommendations on CTIC (CTi Biopharma Corp)?

has 0 price targets and 0 ratings on CTIC

Which analyst is the currently most bullish on CTIC (CTi Biopharma Corp)?

Leah Rush Cann with the highest potential upside of $2.91

Which analyst is the currently most reserved on CTIC (CTi Biopharma Corp)?

Chad Messer with the lowest potential downside of -$3.09
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?